Pulmonary and extrapulmonary infection caused by Mycobacterium conceptionense: the first report from Iran by Shojaei, Hasan et al.
Pulmonary and extrapulmonary
infection caused by Mycobacterium
conceptionense: the first report
from Iran
Hasan Shojaei1 ￿ Abodolrazagh Hashemi1 ￿ Parvin Heidarieh2 ￿
Behrouz Ataei3 ￿ Abass Daei Naser3
1Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2Microbiology Group, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences,
Tehran, Iran
3Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Correspondence to: Hasan Shojaei. Email: hasanshojaei@msn.com
We report what we believe to be the ﬁrst clinical
isolation of Mycobacterium conceptionense in a
developing country.
Case reports
Case one
A 38-year-old man presented to hospital with high
fever, cough, chest pain and 10 kg of weight loss in
6 weeks. His medical record showed that he was a
narcotic addict, IV drug user and infected with
HIV during a course of imprisonment in 2007. He
was negative for tuberculin test and had no
history of infection with mycobacteria. One year
earlier, he had developed cytomegalovirus disease
and candidosis. At admission, laboratory testing
revealed an elevated C-reactive protein (CRP) of
50 mg/L; erythrocyte sedimentation rate (ESR) of
63 mm/h; a viral load of 5000 copies/mL; and a
CD4 T-cell count of 40 cells/mm
3. His chest
X-ray was normal.
Direct microscopic examination of blood speci-
men for acid fast bacilli was negative, but culture
on Lo ¨wenstein-Jensen (LJ) slant yielded colonies
of rapidly growing mycobacterium. Three weeks
after the initiation of amikacin therapy, the
patient showed marked improvement and lived
for one more year before he died of hepato-renal
failure.
Case two
A 57-year-old man admitted to hospital with an
exacerbation of chronic obstructive pulmonary
disease and emphysema. He had been treated for
active pulmonary tuberculosis two years earlier.
Acid fast bacilli were detected in all three
sputum specimens of the patient. This ﬁnding
wasconﬁrmedbyapositivecultureonLJmedium.
Two months later, the isolates were sent to our lab-
oratory with a request for the deﬁnitive identiﬁ-
cation. No more clinical data were provided
regarding this patient due to loss of follow-up.
Case three
A 62-year-old woman was admitted to hospital
because of urinary tract infection with chronic
ﬂank pain. Her major symptoms included
urgency, frequency, dysuria and moderate fever.
Gram staining on mid-stream urine sample
revealed numerous polymorphonuclear leuko-
cytes. Culture of specimen on blood agar and
MacConkey agar was negative. The laboratory
examination results were as follows: haemoglobin
16 gm/dL; white cell count 8.7 ×10
6/cu.mm; ESR
58 mm/h; CRP 30.9 mg/L. Evaluation of sono-
graphic imaging revealed inﬂammation of the
lower urinary tract. Kidney stones were ruled out
by computed tomography (CT) scan.
She had no history of infection with mycobac-
teria and was negative for HIVand other immuno-
suppressive diseases. The acid fast staining of
three consecutive 24-hour mid-stream clean catch
urine specimens were positive, and the culture
on LJ medium yielded pure rapidly growing myco-
bacterium. The patient became afebrile on amikacin
therapy.
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CASE REPORT
1The clinical isolates, namely M71 (case 1), M89
(Case 2), and M137 (case 3), were sent to our
research laboratory in a period of two to three
months after initial isolation for deﬁnitive identiﬁ-
cation. The isolates were subjected to preliminary
identiﬁcation and susceptibility to common antimy-
cobacterial agents forrapidly growing mycobacteria
according to standard procedures.
1,2 They were
then subjected to molecular identiﬁcation which
included PCR restriction fragment length poly-
morphism analysis (PRA algorithm) of a 644-bp
fragment of the hsp65 and direct sequencing analy-
sis of almost full length of 16S rDNA and 16S–23S
internal transcribed spacer (ITS) as well as partial
sequencing of hsp65 and rpoB genes as previously
described.
3–7
GenBank accession numbers for 16S rDNA,
ITS, rpoB, and hsp65 sequences as a representative
isolate determined in this study strain M137 are
GU142926, HM536981, HM536982 and
HM536983, respectively.
Based on phenotypic characteristics, the iso-
lates were non-pigmented mycobacterial species
growing at 25˚C and 37˚C but not at 42˚C. They
grew on LJ medium with 5% NaCl and MacCon-
key agar without crystal violet, were positive for
semi-quantitative and heat-stable catalase,
nitrate, tween hydrolysis, and iron uptake tests;
and were negative for niacin, urease and D-
sorbitol tests. They were susceptible to amikacin,
streptomycin, clarithromycin, doxicycline, sulfa-
methoxazole, imipenem and ciproﬂoxacin.
In PRA analysis all isolates produced frag-
ments of 480/199, 270/161/117 and 254/97 base
pairs in AvaII, HpaII, and HphI digestion, respect-
ively. The PRA proﬁles were distinct from those
of previously characterized mycobacteria
(Figure 1).
3 The reproducibility of PRA assay
was evaluated by including M. fortuitum (ATCC
49403) as a positive internal control. A tube
without DNA template was also included in all
PCR and PRA reactions as a negative control.
Restriction fragments shorter than 97 bp were
not considered to reduce confusion with primer-
dimer bands.
3
The 16S rDNA sequence (1459 bp) of three iso-
lates were identical and showed the highest simi-
larity of 99.86% with that of M. conceptionense and
99.59% with those of type strains of M. fortuitum,
M. porcinum and M. farcinogenes. These values
correspond to two and six nucleotide differences.
The hypervariablesignature sequences oftheinves-
tigated isolates were 100% identical to those of the
type strain of M. conceptionense (Figure 2).
Thehsp65sequencesoftheisolateswereidentical
andshowed 98.53%,97.96%and 97.42% similarities
with those of the type strains of M. conceptionense,
M. farcinogenes and M. fortuitum, repectively. These
values correspond to ﬁve, eight and ninenucleotide
differences. The ITS sequences of the isolates were
identical and showed 100%, 93.16% and 71.11%
similarities with those of the type strains of
M. conceptionense, M. senegalense and M. fortuitum,
repectively. These values correspond to 0, 16 and
65 nucleotide differences. The rpoBs e q u e n c e so f
the investigated isolates were identical and showed
98.84% and 95.71% similarities with those of the
type strains of M. conceptionense and M. fortuitum,
repectively. These values correspond to 5 and 29
nucleotide differences.
Discussion
M. conceptionense was ﬁrst isolated from a wound
infection of a healthy young woman and
described as a novel rapidly growing mycobacter-
ium in 2006.
8 To the best of our knowledge, there
have been only two further reports on isolation
of the organism from clinical specimens in the
world literature.
9,10
Figure 1
PRA patterns obtained from digestion of the ampliﬁed hsp65 gene
of isolates M71 (1), M89 (2), and M137 (3) and with (A) AvaII, (B) HpaII
and (C) HphI restriction enzymes, respectively. Lane 4 represents
M. fortuitum ATCC 49403 which is used as internal control. Lanes
designated M represent the molecular DNA 50 bp size marker
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Tom ParksDeﬁnitive identiﬁcation of the Iranian isolates
as M. conceptionense was achieved by taking into
account phenotypic and molecular characteristics
and in particular the sequencing of key genetic
markers. The etiologic role of the isolates might
be inferred from the fact that acid fast bacilli were
microscopicallyobservedintwooutofthreediffer-
ent clinical specimens. Furthermore, all three iso-
lates were recovered from pure culture. Also, no
such isolate was made in our laboratory in the
past and during the same period of time. On the
other hand, the isolates were made from more
than one diseased specimen in the patients.
In summary, the present study together with
the previous ﬁndings show that M. conceptionense
is capable of infecting avarietyof organs in humans.
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Figure 2
Alignment of selected stretches of ﬁrst hypervariable region (positions 125-270 E. coli numbering system)
of 16SrDNA gene of Iranian isolates of M. conceptionense M71, M89, and M137 with those of closely
related mycobacteria
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